Abu Dhabi-based global health leader M42 has announced a strategic partnership with 10X Health from the USA and REVIV Global from the UK to launch 10XREVIV, a pioneering venture set to introduce a first-of-its-kind Precision Nutrition System to the Middle East.
This collaboration leverages proprietary artificial intelligence to unite genetic insights, blood biomarkers, and nutritional science, aiming to deliver hyper-personalized health optimization at scale across the region.
The Science Behind 10XREVIV
At the core of the new venture is the 10X Precision Nutrition System, a patented life-sciences platform developed over more than a decade. The system’s AI algorithms analyze up to 20 million genetic variations with 99.97 percent accuracy.
By integrating DNA, blood chemistry, and lifestyle data, the platform maps an individual’s unique biological blueprint. This analysis generates a secure, 400-plus-page digital health report that provides actionable insights into areas such as nutrient absorption, metabolic efficiency, immune function, cardiovascular health, and longevity pathways.
From Data To Actionable Health Solutions
The 10XREVIV venture translates this complex data into clinically validated, precision-based interventions. These offerings include 10X Precision Supplements with micro-bead formulations optimized for genetic compatibility and 10X Precision Weight Management Solutions calibrated to individual metabolic profiles.
Additionally, the partnership will offer Precision IV Therapy, featuring globally patented, genetically informed IV protocols. These bespoke micronutrient infusions will be delivered exclusively through approved and certified medical facilities.
Building A Regional HealthTech Ecosystem
Beyond personalized products, the collaboration aims to build a broader health optimization ecosystem. The roadmap includes establishing a Precision Longevity flagship clinic and conducting a randomized control trial to study the impact of IV nutrition on Type 2 Diabetes.
Furthermore, a Precision Nutrition training curriculum will be launched to empower medical practitioners to interpret genetic data and apply it in clinical settings, ultimately enhancing patient outcomes.
Leadership On The Landmark Partnership
Albarah El Khani, Chief Operating Officer of Integrated Health Solutions platform at M42, said, “At M42, we are committed to redefining how healthcare is delivered by integrating AI, data, and life sciences to unlock human potential. Our partnership with 10X Health and REVIV Global represents a significant step toward precision-based, predictive and preventive care — where insights from genetics and biomarkers directly inform how we nourish, restore, and optimize the human body.”
Brandon Dawson, Co-Founder, Chairman and CEO of 10X Health, stated, “Partnering with M42 & REVIV Global allows us to expand the reach of our proprietary 10X Precision System into one of the most forward-thinking healthcare ecosystems in the world. Together, we are creating a new global benchmark for human optimization — where science, technology, and clinical application converge.”
Sarah Lomas, CEO and Founder of REVIV Global, commented, “REVIV has long been at the forefront of IV-based therapies and global wellness innovation. This alliance with 10X Health and M42 elevates our vision by combining cutting-edge genetics, AI-driven nutrition and world-class clinical delivery. We are excited to bring these advanced solutions to the Middle East and help define a future of longevity and precision health.”
About M42
M42 is an Abu Dhabi-based global health powerhouse that combines G42 Healthcare’s unique medical and data-centric technologies with Mubadala Health’s world-class patient care. The company is dedicated to leveraging technology, AI, and genomics to deliver transformative and sustainable health solutions.
Source: Zawya
